Literature DB >> 34822743

Occupational chronic obstructive pulmonary disorder: prevalence and prevention.

Jordan Minov1.   

Abstract

INTRODUCTION: Occupational chronic obstructive pulmonary disorder, i.e. work-related asthma (WRA) and occupational chronic obstructive pulmonary disease (COPD), are the most common occupational lung diseases in the last decades worldwide. As in the case of the other occupational disorders, these diseases may be prevented. AREAS COVERED: WRA is a heterogeneous entity that includes three subtypes, immunologic occupational asthma (OA), irritant-induced asthma (IIA), and work-exacerbated asthma (WEA), depending on the role of occupational exposures as a causing or aggravating factor of the disease. In addition, there is consistent evidence that a substantial proportion of COPD cases can be explained by exposure to noxious particles and gases other than tobacco smoke, such as workplace dusts, gases, fumes, and vapors. The articles cited in this paper were searched by keywords in several databases in the period up to May-July 2021. EXPERT OPINION: The development of occupational chronic obstructive disorder is a matter of prevention. WRA and occupational COPD contribute significantly to the overall burden of asthma and COPD. Activities and measures targeted to elimination or reduction of harmful workplace exposures, as well as to early detection and early intervention in the course of the lung damage, can significantly reduce the burden caused by these diseases.

Entities:  

Keywords:  Occupational asthma; occupational COPD; occupational exposures; work-exacerbated asthma; work-related asthma

Mesh:

Substances:

Year:  2021        PMID: 34822743     DOI: 10.1080/17476348.2021.2011722

Source DB:  PubMed          Journal:  Expert Rev Respir Med        ISSN: 1747-6348            Impact factor:   3.772


  1 in total

1.  Management of acute exacerbation of chronic obstructive pulmonary disease under a tiered medical system in China.

Authors:  Xiaojing Liu; Chunlin Du; Fuying Hu; Yunfeng Zhao; Jintao Zhou; Qian Wang; Yutong Mu; Jinchang Lu; Lei Gao; Bo Cui; Yuan Ma; Tieying Sun; Feng Qian; Zhihong Chen
Journal:  Ther Adv Respir Dis       Date:  2022 Jan-Dec       Impact factor: 4.031

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.